- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PHARMACIELO Aktie jetzt für 0€ handeln | |||||
| Fr | PharmaCielo Ltd.: PharmaCielo Reports Q4 2024 Financial Results | 175 | Newsfile | PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million.Revenues and Gross Profit Margin Increased with More Diverse Customer Base.Q4 Cash Flow... ► Artikel lesen | |
| 12.02. | Pharmacielo Ltd: Pharmacielo issues settlement, interest shares | 2 | Stockwatch | ||
| 12.02. | PharmaCielo Ltd.: PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing | 211 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - February 12, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 02.12.24 | PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025 | 4 | Benzinga.com | ||
| 02.12.24 | PharmaCielo Ltd.: PharmaCielo Reports Q3 2024 Financial Results | 210 | Newsfile | PharmaCielo achieved 85% Year-Over-Year Sales Growth, Generating Year-to-Date Q3 Total Revenue of $2.4 MillionQ3 Gross Profit Turned Positive Reflecting More Diverse Customer BaseQ3 Cash Flow Improved... ► Artikel lesen | |
| 13.11.24 | Pharmacielo Ltd: Pharmacielo 9,007,200 warrants extended | 3 | Stockwatch | ||
| 05.11.24 | Pharmacielo Ltd: Pharmacielo to extend nine million warrants by one year | 3 | Stockwatch | ||
| 05.11.24 | PharmaCielo Ltd.: PharmaCielo Announces Intention to Extend Expiry Date of Warrants | 463 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 5, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 11.10.24 | Pharmacielo Ltd: Pharmacielo 5,979,496 shares for debt | 1 | Stockwatch | ||
| 08.10.24 | Pharmacielo Ltd: Pharmacielo appoints auditor, changes year-end | 152 | Stockwatch | ||
| 07.10.24 | PharmaCielo Ltd.: PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024 | 401 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 7, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 16.08.24 | PharmaCielo Ltd.: PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024 | 328 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 16, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 17.07.24 | PharmaCielo Ltd.: PharmaCielo Provides Update on Reinstatement for Trading | 414 | Newsfile | Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier... ► Artikel lesen | |
| 04.07.24 | PharmaCielo Ltd.: PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024 | 473 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 08.05.24 | PharmaCielo Ltd.: PharmaCielo Announces Issuance of Failure to File Cease Trade Order | 158 | Newsfile | All amounts expressed in Canadian dollars unless otherwise notedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
| 10.04.24 | PharmaCielo Ltd.: PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors | 522 | Newsfile | The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product.Experienced investor... ► Artikel lesen | |
| 26.03.24 | PharmaCielo Ltd.: PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil | 269 | Newsfile | The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to... ► Artikel lesen | |
| 01.03.24 | PharmaCielo Ltd.: Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo | 444 | Newsfile | Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 22,710 | -0,15 % | Bayer treibt digitale Landwirtschaft voran: Kann Innovation die Probleme lösen? | Bayer AG (ISIN: DE000BAY0017) steht vor einem entscheidenden Wandel. CEO Bill Anderson hat ehrgeizige Pläne zur Umstrukturierung des Konzerns angekündigt, mit dem Ziel, Bürokratie abzubauen und Bayer... ► Artikel lesen | |
| AURORA CANNABIS | 4,866 | -0,94 % | Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain? | ||
| CANOPY GROWTH | 1,356 | +0,74 % | Canopy Growth establishes $200M at-the-market program | ||
| TILRAY BRANDS | 0,710 | +0,31 % | Tilray Brands, Inc. - 8-K, Current Report | ||
| INNOCAN PHARMA | 0,140 | +2,19 % | InnoCan Pharma: Großaktionär erhöht den Bestand auf über 20%?! | ||
| TAAT GLOBAL ALTERNATIVES | 0,169 | +11,96 % | TAAT Global Alternatives, Inc. unterzeichnet eine unverbindliche Absichtserklärung zur Übernahme von Premium Products LLC, um sein alternatives Produktportfolio zu erweitern | Vancouver, BC, 17. Januar 2025 / IRW-Press / TAAT Global Alternatives, Inc. (CSE: TAAT) (OTCQX: TOBAF) (FWB: 2TP) (das "Unternehmen" oder "TAAT") freut sich, die
Unterzeichnung einer unverbindlichen... ► Artikel lesen | |
| DERMAPHARM | 38,600 | -1,03 % | Dermapharm: Aktie wird abgestuft | 2024 ist für Dermapharm gut verlaufen. Die Analysten von mwb research gehen davon aus, dass die Gesellschaft ihre Jahresprognose schaffen wird. Dermapharm rechnet mit einem Umsatz von 1,17 Milliarden... ► Artikel lesen | |
| CRONOS GROUP | 1,999 | +0,91 % | Cronos Group Inc.: Cronos Group Reports 2024 Fourth Quarter and Full-Year Results | Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million Spinach® Ends 2024 as the Number One Cannabis Brand... ► Artikel lesen | |
| DOCMORRIS | 22,160 | -1,51 % | Adhoc: DocMorris AG: EuGH-Urteil zur Werbung beim Bezug verschreibungspflichtiger Arzneimittel | DocMorris AG / Schlagwort(e): Rechtssache
DocMorris AG: EuGH-Urteil zur Werbung beim Bezug verschreibungspflichtiger Arzneimittel
27.02.2025 / 12:36 CET/CEST
Veröffentlichung einer Ad-hoc-Mitteilung... ► Artikel lesen | |
| SYNBIOTIC | 3,510 | -3,57 % | SYNBIOTIC plant weitere Übernahmen in 2025 | Mitteilung der SYNBIOTIC SE: SYNBIOTIC mit vier neuen Beteiligungen in 2024: Weitere Übernahmen für 2025 in Sicht Die europäische Industriehanf- und Cannabis-Unternehmensgruppe SYNBIOTIC SE (ISIN DE000A3E5A59... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
| ORGANIGRAM | 1,140 | +2,33 % | Organigram Reports First Quarter Fiscal 2025 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the first quarter... ► Artikel lesen | |
| CRESCO LABS | 0,835 | +0,18 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,780 | +1,88 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2024 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,541 | -0,39 % | SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025 |
PHARMACIELO LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMACIELO LTD finden Sie auf Wallstreet Online.
